Twist Bioscience Corp. (TWST)
124.72
-3.99
(-3.10%)
USD |
NASDAQ |
Sep 04, 16:00
124.20
-0.52
(-0.42%)
After-Hours: 20:00
Twist Bioscience SG&A Expense (TTM) : 290.29M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 290.29M |
| March 31, 2026 | 272.96M |
| December 31, 2025 | 260.54M |
| September 30, 2025 | 246.98M |
| June 30, 2025 | 236.36M |
| March 31, 2025 | 229.78M |
| December 31, 2024 | 221.74M |
| September 30, 2024 | 218.40M |
| June 30, 2024 | 212.65M |
| March 31, 2024 | 201.91M |
| December 31, 2023 | 200.25M |
| September 30, 2023 | 189.74M |
| June 30, 2023 | 196.50M |
| March 31, 2023 | 204.14M |
| December 31, 2022 | 204.17M |
| September 30, 2022 | 212.95M |
| June 30, 2022 | 197.03M |
| March 31, 2022 | 177.82M |
| December 31, 2021 | 158.21M |
| September 30, 2021 | 135.90M |
| Date | Value |
|---|---|
| June 30, 2021 | 124.84M |
| March 31, 2021 | 112.85M |
| December 31, 2020 | 105.65M |
| September 30, 2020 | 103.27M |
| June 30, 2020 | 100.50M |
| March 31, 2020 | 99.34M |
| December 31, 2019 | 91.27M |
| September 30, 2019 | 80.13M |
| June 30, 2019 | 68.66M |
| March 31, 2019 | 58.59M |
| December 31, 2018 | 49.45M |
| September 30, 2018 | 43.45M |
| June 30, 2018 | 38.91M |
| March 31, 2018 | 33.57M |
| December 31, 2017 | 29.58M |
| September 30, 2017 | 26.06M |
| June 30, 2017 | 17.65M |
| March 31, 2017 | 11.73M |
| December 31, 2016 | 5.74M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Beam Therapeutics, Inc. | 125.40M |
| Intellia Therapeutics, Inc. | 136.25M |
| Prime Medicine, Inc. | 54.39M |
| Absci Corp. | 35.28M |
| Generate Biomedicines, Inc. | 27.12M |